Drugs@FDA: FDA-approved drug database checked for 5-Amino-1MQ on July 30, 2026
However, AOD-9604 is not a replacement for diet and exercise but rather an enhancement
Once reconstituted, maintain at 28C and protect from excessive heat, moisture, and direct light
SLU-PP-332 is a novel synthetic pan-agonist of the estrogen-related receptors (ERR, ERR, ERR), originally developed at Saint Louis University and characterised in recent pre-clinical literature as an exercise mimetic. It is widely studied in research models exploring mitochondrial biogenesis, fatty-acid oxidation, and metabolic endurance
Unlike some peptides that mainly reduce appetite, 5-Amino-1MQ targets the NNMT enzyme to prevent fat storage, supporting a metabolic approach to fat loss rather than simply appetite suppression Yes, 5-Amino-1MQ can be used in combination with other therapies like GLP-1 for enhanced weight loss and metabolic support